According to a new market report published by Lucintel, the future of the global prefilled syringe market looks promising with opportunities in hospitals/clinics and ambulatory surgical centers. The global prefilled syringe market is expected to reach an estimated $10.8 billion by 2027 with a CAGR of 9.5% from 2022 to 2027. The major drivers for this market are the increasing prevalence of chronic diseases and growing home-based healthcare market.
In this market, conventional and safety prefilled syringes are the various product types. On the basis of comprehensive research, Lucintel forecasts that conventional prefilled syringes will remain the largest segment, and it is also expected to witness the highest growth over the forecast period due to increasing prevalence of chronic devices like diabetes, cancer, and autoimmune diseases.
Within the global prefilled syringe market, anaphylaxis, diabetes, and rheumatoid arthritis are the major application segments. Diabetes will remain the largest application segment over the forecast due to rise in adoption of injectable devices, surges in the advantages of prefilled syringes, and growing prevalence of diabetes, and the need for effective and safer insulin delivery devices .
APAC will remain the fastest growing region over the forecast period due to improvements in healthcare infrastructure, a rise in number of hospitals equipped with advanced instruments, and development of the R&D sector.
Emerging trends, which have a direct impact on the dynamics of the industry, include the usage of syringe plunger stopper for enhanced biologic drug delivery and usage of finer needles or microneedles in prefilled syringes. Becton, Dickinson, and Company, Gerresheimer AG, B. Braun Melsungen, Schott AG, and Baxter International are among the major players in the prefilled syringe market.
Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global prefilled syringe market by material, product type, design, application, end user, and region, and has compiled a comprehensive research report titled “Growth Opportunities in the Global Prefilled syringe Market 2022-2027: Trends, Forecast, and Opportunity Analysis.” The Lucintel report serves as a catalyst for growth strategy by providing comprehensive data and analysis on trends, key drivers, and directions. The study includes trends and forecast for the global prefilled syringe market by material, product type, design, application, end user, and region, as follows:
By Material [Value ($ Million) from 2016 to 2027]:
Glass-Based
Plastic-Based
By Product Type [Value ($ Million) from 2016 to 2027]:
By Design [Value ($M) from 2016 to 2027]:
Single-Chamber
Dual-Chamber
Customized
By Application [Value ($M) from 2016 to 2027]:
Anaphylaxis
Diabetes
Rheumatoid Arthritis
Others
By End User [Value ($ Million) from 2016 to 2027]:
Hospitals/Clinics
Ambulatory Surgical Centers
Others
By Region [Value ($ Million) from 2016 to 2027]:
North America
Europe
United Kingdom
France
Germany
Italy
Spain
APAC
ROW
This 226-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link…… or helpdesk@lucintel.com.
About Lucintel
Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision makers in a variety of industries. For further information, visit www.lucintel.com.
This report addresses the following key questions:
Q.1 What are some of the most promising growth opportunities for the global prefilled syringe market by material (glass-based and plastic-based), product type (conventional and safety), design (single chamber, dual chamber, and customized), application (anaphylaxis, diabetes, rheumatoid arthritis, and others), end user (hospitals/clinics, ambulatory surgical centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges, and business risks in this market?
Q.5 What are the business risks and competitive threats in this market?
Q.6 What are the emerging trends in this market and the reasons behind them?
Q.7 What are some of the changing demands of customers in the market?
Q.8 What are the new developments in the market and which companies are leading these developments?
Q.9 Who are the major players in this market? What strategic initiatives are being taken by key players for business growth?
Q.10 What are some of the competing products in this market and how big of a threat do they pose for loss of market share by product substitution?
Q.11 What M & A activity has occurred in the last 5 years?